Inspire Medical Systems, Inc. (INSP)
USD 159.81
(1.21%)
USD 159.81
(1.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 33.88 Million USD | 185.08% |
| 2022 | 11.88 Million USD | -31.02% |
| 2021 | 17.23 Million USD | 103.22% |
| 2020 | 8.47 Million USD | 45.34% |
| 2019 | 5.83 Million USD | 118.75% |
| 2018 | 2.66 Million USD | -27.33% |
| 2017 | 3.67 Million USD | 9.39% |
| 2016 | 3.35 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 48.97 Million USD | 44.53% |
| 2024 Q2 | 59.02 Million USD | 20.52% |
| 2024 Q3 | 67.43 Million USD | 14.24% |
| 2023 FY | 33.88 Million USD | 185.08% |
| 2023 Q3 | 26.11 Million USD | 25.31% |
| 2023 Q2 | 20.84 Million USD | 33.05% |
| 2023 Q1 | 15.66 Million USD | 31.78% |
| 2023 Q4 | 33.88 Million USD | 29.75% |
| 2022 Q1 | 22.19 Million USD | 28.83% |
| 2022 Q4 | 11.88 Million USD | -21.52% |
| 2022 FY | 11.88 Million USD | -31.02% |
| 2022 Q3 | 15.14 Million USD | -30.7% |
| 2022 Q2 | 21.85 Million USD | -1.54% |
| 2021 Q1 | 11.38 Million USD | 34.27% |
| 2021 FY | 17.23 Million USD | 103.22% |
| 2021 Q4 | 17.23 Million USD | 10.64% |
| 2021 Q3 | 15.57 Million USD | 17.13% |
| 2021 Q2 | 13.29 Million USD | 16.79% |
| 2020 Q4 | 8.47 Million USD | -5.43% |
| 2020 Q1 | 7.24 Million USD | 24.19% |
| 2020 FY | 8.47 Million USD | 45.34% |
| 2020 Q2 | 9.96 Million USD | 37.56% |
| 2020 Q3 | 8.96 Million USD | -10.03% |
| 2019 Q1 | 3.1 Million USD | 16.46% |
| 2019 FY | 5.83 Million USD | 118.75% |
| 2019 Q4 | 5.83 Million USD | 24.79% |
| 2019 Q3 | 4.67 Million USD | 31.28% |
| 2019 Q2 | 3.56 Million USD | 14.65% |
| 2018 Q3 | 3.07 Million USD | -13.33% |
| 2018 FY | 2.66 Million USD | -27.33% |
| 2018 Q2 | 3.54 Million USD | 4.54% |
| 2018 Q1 | 3.39 Million USD | -7.52% |
| 2018 Q4 | 2.66 Million USD | -13.27% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 3.67 Million USD | 0.0% |
| 2017 FY | 3.67 Million USD | 9.39% |
| 2016 FY | 3.35 Million USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 99.484% |
| Allurion Technologies Inc. | 6.17 Million USD | -449.101% |
| Artivion, Inc. | 81.97 Million USD | 58.665% |
| Avanos Medical, Inc. | 163.2 Million USD | 79.237% |
| Butterfly Network, Inc. | 75.83 Million USD | 55.319% |
| Butterfly Network, Inc. | 75.83 Million USD | 55.319% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 95.659% |
| Boston Scientific Corporation | 2.48 Billion USD | 98.636% |
| CONMED Corporation | 318.32 Million USD | 89.355% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 97.099% |
| Paragon 28, Inc. | 98.06 Million USD | 65.445% |
| Glaukos Corporation | 41.98 Million USD | 19.295% |
| Globus Medical, Inc. | 848.13 Million USD | 96.005% |
| Integer Holdings Corporation | 239.71 Million USD | 85.865% |
| Medtronic plc | 5.21 Billion USD | 99.35% |
| Myomo, Inc. | 1.8 Million USD | -1778.839% |
| Nevro Corp. | 118.67 Million USD | 71.447% |
| Owlet, Inc. | 6.49 Million USD | -421.87% |
| Penumbra, Inc. | 388.02 Million USD | 91.267% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 98.585% |
| STERIS plc | 674.53 Million USD | 94.977% |
| Stryker Corporation | 4.84 Billion USD | 99.3% |
| Vapotherm, Inc. | 22.96 Million USD | -47.531% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 98.579% |